UY25369A1 - PROCEDURE FOR PREPARING PROTEASE INHIBITORS - Google Patents

PROCEDURE FOR PREPARING PROTEASE INHIBITORS

Info

Publication number
UY25369A1
UY25369A1 UY25369A UY25369A UY25369A1 UY 25369 A1 UY25369 A1 UY 25369A1 UY 25369 A UY25369 A UY 25369A UY 25369 A UY25369 A UY 25369A UY 25369 A1 UY25369 A1 UY 25369A1
Authority
UY
Uruguay
Prior art keywords
alkyl
het
procedure
protease inhibitors
alkenyl
Prior art date
Application number
UY25369A
Other languages
Spanish (es)
Inventor
W Marquis Robert
Yu Ru
F Veber Daniel
M Locastro Stephen
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of UY25369A1 publication Critical patent/UY25369A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un procedimiento para preparar compuestos derivados de pirrolidina (ver formula l en solicitud), en la que Y es Ar o NR1R2; R3 es H, alquenilo, alquinilo, Het, Ar, o alquilo opcionalmente sustituido con OR', SR', NR'2, N(C=NH)NH2, R4 es H, alquilo, alquenilo, Ar-alquilo, o Het-alquilo; R5 es Ar-alquilo, Het-alquilo, adamantil-C(O)-, Ar-C(O), etc; N es 1, 2, o 3; R''' es H, alquilo, cicloalquil-alquilo, Ar-alquilo o Het-alquilo; o una sal farmacéuticamente aceptable de losmismos; que son inhibidores de proteasas de cisteína , en particular de la catepsina K, Y son útiles en el tratamiento de enfermedades en las que la inhibición de la pérdidad ósea es un factor.A process for preparing compounds derived from pyrrolidine (see formula 1 in application), wherein Y is Ar or NR1R2; R3 is H, alkenyl, alkynyl, Het, Ar, or alkyl optionally substituted with OR ', SR', NR'2, N (C = NH) NH2, R4 is H, alkyl, alkenyl, Ar-alkyl, or Het- I rent; R5 is Ar-alkyl, Het-alkyl, adamantyl-C (O) -, Ar-C (O), etc; N is 1, 2, or 3; R '' 'is H, alkyl, cycloalkyl-alkyl, Ar-alkyl or Het-alkyl; or a pharmaceutically acceptable salt thereof; which are inhibitors of cysteine proteases, particularly cathepsin K, and are useful in the treatment of diseases in which inhibition of bone loss is a factor.

UY25369A 1997-05-08 1999-01-25 PROCEDURE FOR PREPARING PROTEASE INHIBITORS UY25369A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4686597P 1997-05-08 1997-05-08
UY24991 1998-05-06

Publications (1)

Publication Number Publication Date
UY25369A1 true UY25369A1 (en) 1999-11-17

Family

ID=71093377

Family Applications (1)

Application Number Title Priority Date Filing Date
UY25369A UY25369A1 (en) 1997-05-08 1999-01-25 PROCEDURE FOR PREPARING PROTEASE INHIBITORS

Country Status (1)

Country Link
UY (1) UY25369A1 (en)

Similar Documents

Publication Publication Date Title
BR0212042A (en) Compound, pharmaceutical composition, method of treating or preventing disease, and use of a compound
GB0005251D0 (en) Therapeutic compounds
IL165262A (en) Kinase inhibitors and pharmaceutical compositions containing them
ATE334668T1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISEASES
DE60329316D1 (en) PHENYL ACARBOXAMIDE AS A BETA SEKRETASE INHIBITOR FOR THE TREATMENT OF ALZHEIMER
FI950309A0 (en) proline amide derivative
EA200200208A1 (en) SYNERGY COMPOSITION
DE60124684D1 (en) SULPHONAMIDO-SUBSTITUTED BROKEN BICYCLOALKYL DERIVATIVES
GB0223040D0 (en) Therapeutic compounds
SI1509232T1 (en) A combination of an nmda-antagonist and acetylcholine esterase inhibitors for the treatment of alzheimer's disease
IL165264A (en) Protein kinase inhibitors, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for treating protein kinase-associated diseases
LU91145I2 (en) FIROCOXIB optionally in the form of a pharmaceutically acceptable salt (PREVICOX).
TR199901191T2 (en) Use of benzamidoaldehydes as cysteine protease inhibitors.
GEP20053600B (en) 3-(4-Amidopyrrol-2-Ylmethlidene)-2- Indolinone Derivatives as Protein Kinase Inhibitors
WO1998033491A3 (en) Treatment of arrhythmias via inhibition of a multifunctional calcium/calmodulin-dependent protein kinase
MXPA04003245A (en) Hydroxypropylamines.
MXPA04002785A (en) Substituted amines for the treatment of alzheimer's disease.
UY25143A1 (en) PROCEDURE FOR THE PREPARATION OF PROTEASE INHIBITORS.
DE60025848D1 (en) Pyrimidin-derivate als selective inhibitoren von cox-2
GEP20074045B (en) (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease
DE60205899D1 (en) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
DE60312736D1 (en) 1,2,4-TRIAMINOBENZOLE DERIVATIVES FOR THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM
MXPA03011466A (en) Macrocycles useful in the treatment of alzheimer's disease.
BG106293A (en) Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
ATE326964T1 (en) AMINO ACID DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE

Legal Events

Date Code Title Description
RDES Application refused

Effective date: 20010525